Pharmacokinetic Study of Doxorubicin in Children With Cancer

NCT01095926 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

101

Enrollment

OTHER

Sponsor class

Conditions

Wilms Tumor
Neuroblastoma
Soft Tissue Sarcoma
Acute Lymphoblastic Leukemia

Interventions

DRUG: doxorubicin

Sponsor

University Hospital Muenster